TCMBANKIN028171 |
Isobergapten |
Spectrum_000630; NCGC00095572-03; isobergapten; UNII-27X3V737WH; Spectrum5_000029; AC1L28ZS; 5-Methoxy-2H-furo(2,3-h)-1-benzopyran-2-one; SCHEMBL2253427; KBio2_001110; HMS2201F13; ZINC1846642; 2H-Furo[2,3-h]-1-benzopyran-2-one,5-methoxy-; 5-Methoxy-2H-furo[2,3-H]chromen-2-one; NCGC00095572-02; CHEBI:81487; 27X3V737WH; AC1Q6BDY; AKOS000277832; Spectrum2_000313; 5-methoxy-angelicin; KBio1_001192; C-11619; 2H-Furo[2,3-h]-1-benzopyran-2-one, 5-methoxy-; KBio2_006246; NCGC00095572-01; C18082; MEGxp0_000707; FT-0603415; Spectrum3_001226; 5-methoxyfurano[2,3-h]chromen-8-one; SpecPlus_000152; SR-01000721827; SMR000156214; 5-Methoxy-furo[2,3-h]chromen-2-one; AK144796; 2H-Furo(2,3-h)-1-benzopyran-2-one, 5-methoxy-; KBioSS_001110; 5-Hydroxyangelicin methylether; 5-methoxyfuro[2,3-h]chromen-2-one; AJ-31925; 5-methoxy-2-furo[2,3-h]chromenone; MolPort-000-882-155; KBioGR_001929; KBio2_003678; TX-017650; SR-01000721827-2; DivK1c_006248; AJSPSRWWZBBIOR-UHFFFAOYSA-N; HMS3330D17; 482-48-4; CHEMBL141690; ST24044839; ST50331507; MLS000574855; SDCCGMLS-0066519.P001; SPBio_000306; CJ-30271; 5-Methoxy-2H-furo[2,3-H]chromen-2-one #; X1164; CTK4J0734; ST5331507; DTXSID8075415; NCGC00178537-01; BSPBio_002672; SPECTRUM300032; Spectrum4_001445; 5-Methoxyangelicin; CCG-38589; 5-methoxy-2h-furo[2,3-h]chromen-2-on; MFCD00016756; KBio3_002172; BRD-K31678817-001-02-0; Isobergaptene |
C12H8O4 |
216.19 |
COC1=C2C=CC(=O)OC2=C3C=COC3=C1 |
TCMBANKIN059084 |
Byakangelicin |
(R)-9-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; 9-[(2S)-2,3-dihydroxy-3-methylbutoxy]-4-methoxyfuro[3,2-g]chromen-7-one; 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxy-7-furo[3,2-g]chromenone; 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxyfuro[3,2-g]chromen-7-one; C09141; 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-, (R)-; 9-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; Byak-angelicin; Bjacangelicin; MLS000574875; Bjakangelicin; PKRPFNXROFUNDE-NSHDSACASA-N; SMR000156212; Biacangelicin; 7H-FURO(3,2-g)(1)BENZOPYRAN-7-ONE, 9-(2,3-DIHYDROXY-3-METHYLBUTOXY)-4-METHOXY-,; 9-[(2R)-2,3-dihydroxy-3-methyl-butoxy]-4-methoxy-furo[3,2-g]chromen-7-one; ZINC13380829; 482-25-7; AC1NST7W; Byankagelicine; (+)-Byakangelicin; byakangelicin; 9-(2,3-dihydroxy-2-methylbutoxy)-4-methoxy-7H-furo[3,2-g][l]benzopyran-7-one; byak-angelicin |
C17H18O7 |
334.3 g/mol |
CC(C)(C(COC1=C2C(=C(C3=C1OC(=O)C=C3)OC)C=CO2)O)O |
TCMBANKIN059475 |
bya-kangelicol |
|
C17H16O6 |
316.3 g/mol |
CC1(C(O1)COC2=C3C(=C(C4=C2OC(=O)C=C4)OC)C=CO3)C |
TCMBANKIN061880 |
herniarin |
7-methoxycoumarin; 7- methoxy coumarin; Ayapanin220337_ALDRICH; NSC404559; 7-methoxychromen-2-one; DivK1c_006418; KBioGR_002056; Herniarine; KBio2_006008; KBio3_001206; 2H-1-BENZOPYRAN-2-ON; E, 7-METHOXY-; SDCCGMLS-0066524.P001; Herniarin; 531-59-9; 7-Methoxycoumarin; MEGxp0_000150; ACon1_002037; 64951_FLUKA; 7-Methoxy-2H-1-benzopyran-2-one; 5-18-01-00387 (Beilstein Handbook Reference); C09268; SPBio_000615; NSC 404559; 7-methoxy-2-chromenone; METHOXYCOURMARIN, 7-; BSPBio_001706; Spectrum_000392; KBio2_003440; KBioSS_000872; ST5406549; Spectrum3_000263; EINECS 208-513-3; Methyl umbelliferyl ether; MLS000574914; AIDS026313; SPECTRUM210874; Spectrum4_001558; Spectrum2_000398; Herniarin (6CI); KBio2_000872; SpecPlus_000322; Coumarin, 7-methoxy-; Spectrum5_000156; ZINC00391177; Coumarin, 7-methoxy- (8CI); W515809_ALDRICH; AIDS-026313; Methylumbelliferone; BRN 0141728; KBio1_001362; NCGC00095528-01; SMR000156201 |
C10H8O3 |
176.17 g/mol |
COC1=CC2=C(C=C1)C=CC(=O)O2 |